产品详情
简单介绍：
Anti-LYPD3抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-LYPD3抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-LYPD3
Cat. Number:
Anti-LYPD3抗体KL-18572R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
LYPD3 is a 346 amino acid cell membrane protein that supports cell migration. Implicated in tumor progression and urothelial cell-matrix interactions, LYPD3 is expressed in skin, urothelium and placenta, with weak levels found in peripheral blood mononuclear cells and esophagus. Upregulated in migrating keratinocytes, LYPD3 undergoes post-translational N- and O-glycosylation, and contains two UPAR/Ly6 domains.
Anti-LYPD3抗体The gene encoding LYPD3 maps to human chromosome 19q13.31. Chromosome 19 consists of over 63 million bases, houses approximately 1,400 genes and is recognized for having the greatest gene density of the human chromosomes. It is the genetic home for a number of immunoglobulin (Ig) superfamily members, including the killer cell and leukocyte Ig-like receptors, a number of ICAMs, the CEACAM and PSG families, and Fc receptors (FcRs).
Also known as:
1600019D15Rik; 2310061G07Rik;
Anti-LYPD3抗体C4.4A; FLJ10525; GPI-anchored metastasis-associated protein C4.4A homolog; GPI-anchored metastasis-associated protein homolog; Ly6/PLAUR domain-containing protein 3; Lypd3; LYPD3_HUMAN; Matrigel-induced gene C4 protein; MIG-C4; OTTHUMP00000125225; OTTHUMP00000218396; OTTHUMP00000218397; SHINC3.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Rabbit, .
●
Immunogen: KLH conjugated synthetic
Anti-LYPD3抗体peptide derived from human LYPD3.
●
Predicted Molecular Weight: 33kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-LYPD3抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-LYPD3抗体
Optimal working dilutions must be determined by the end user.
